Evidence map›Paper›PMID 36389263›Full record

ArticleBiofilm2022

Comparison of cell viability assessment and visualization of

Aswathy Shailaja, Terri F Bruce, Patrick Gerard, Rhonda R Powell, Charles A Pettigrew, Julia L Kerrigan

Open access · goldAbstract read
In one paragraph

Article in Biofilm, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Antibiofilm activity of terbinafine, itraconazole and their combination against Sporothrix brasiliensis yeast-like form's biofilms.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  7. Surfactin-ProducingFoods (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aswathy ShailajaDepartment of Plant and Environmental Sciences, Clemson University, Clemson, SC, USA.
Terri F BruceClemson Light Imaging Facility, Clemson University, Clemson, SC, USA.
Patrick GerardDepartment of Mathematical Sciences, Clemson University, Clemson, SC, USA.
Rhonda R PowellClemson Light Imaging Facility, Clemson University, Clemson, SC, USA.
Charles A PettigrewProcter & Gamble, Global Microbiology, Mason, OH, USA.
Julia L KerriganDepartment of Plant and Environmental Sciences, Clemson University, Clemson, SC, USA.
Clemson University · USProcter & Gamble (United States) · US

Funding

Regulation of Cryptosporidium DevelopmentP20GM146584 · NIGMS · CLEMSON UNIVERSITY · PI Katelyn Ann Walzer · 2022 to 2026
$13.5M
NIGMS NIH HHS P20 GM146584
6 · The paper itself

Abstract

Filamentous fungi are ubiquitous and frequent components of biofilms. A means to visualize them and quantify their viability is essential for understanding their development and disruption. However, quantifying filamentous fungal biofilms poses challenges because, unlike yeasts and bacteria, they are not composed of discrete cells of similar size. This research focused on filamentous fungal biofilms that are representative of those in the built environment. The objective of this study was to develop a rapid method to examine biofilm structure and quantify live (metabolically active/ membrane undamaged) and dead (inactive/ membrane damaged) cells in

Indexed as

Aspergillus nigerCell viabilityCOMSTATConfocal laser scanning microscopyFilamentous fungal biofilmsFluorescent probesXTT assay

Identifiers

PMID36389263
PMCPMC9646680
OpenAlexW4307610497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.